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Abstract
Background: A characteristic of Plasmodium falciparum infections is the gradual acquisition of clinical immunity resulting
from repeated exposures to the parasite. While the molecular basis of protection against clinical malaria remains
unresolved, its effects on epidemiological patterns are well recognized. Accumulating epidemiological data constitute a
valuable resource that must be intensively explored and interpreted as to effectively inform control planning.
Methodology/Principal Finding: Here we apply a mathematical model to clinical data from eight endemic regions in sub-
Saharan Africa. The model provides a quantitative framework within which differences in age distribution of clinical disease
are assessed in terms of the parameters underlying transmission. The shorter infectious periods estimated for clinical
infections induce a regime of bistability of endemic and malaria-free states in regions of mesoendemic transmission. The
two epidemiological states are separated by a threshold that provides a convenient measure for intervention design.
Scenarios of eradication and resurgence are simulated.
Conclusions/Significance: In regions that support mesoendemic transmission, intervention success depends critically on
reducing prevalence below a threshold which separates endemic and malaria-free regimes.
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Introduction
Approximately 2.2 billion people are affected by Plasmodium
falciparum in 86 endemic countries, resulting in about 515 million
clinical cases worldwide and over 1 million fatalities in Africa every
year [1,2]. A characteristic of P. falciparum infections is the gradual
acquisition of clinical immunity resulting from repeated exposures
to the parasite [3]. However, any given infection produces a
clinical outcome that depends on a combination of parasite,
vector, host and environmental factors [4]. In highly endemic
regions, both prevalence of infection and incidence of severe
malaria are high in young children [5,6] and pregnant women [7],
whereas in older children and adults prevalence of infection is
higher, while incidence of severe cases is lower. Thus, even after
many exposures, humans are not resistant to infection, but develop
clinical immunity that prevents symptomatic disease [5,6], which
is not solely dependent on host intrinsic age factors [8]. In low-
endemic regions, however, malaria infection and morbidity show
less age dependence, with infections being commonly symptomatic
even in adults, due to less frequent immunologic stimulation [9].
Understanding the mechanism of acquisition of clinical immunity
has become a classical problem in malaria research. Approaches to
resolve this puzzle involve the development of comprehensive yet
parsimonious mathematical models [10–15]. Here, we construct a
model of malaria transmission incorporating immunological aspects
into an epidemiological framework to infer how acquisition of
immunity is translated into distinct age distributions of clinical
malaria in different populations. We observe that acquisition of
clinical immunity modulates the duration of infections, which in turn
is responsible for the identification of transmission regimes where
stable endemic equilibria coexist with stable disease-free solutions.
This phenomenon, termed bistability, has important implication for
public health which will be discussed.
The model and methodologies developed here are not bound to
the data, in the type and form presented here, and can be used
with other data sets if desired.
Methods
Transmission model
The model is represented diagrammatically in Figure 1 and
formalised by the system of differential equations:
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We consider that infections in immunologically naı¨ve individ-
uals (S) progress to a clinical form of malaria, requiring treatment,
that we will henceforth call clinical malaria (I1). This group
comprises both uncomplicated cases of clinical malaria which are
treated without hospitalisation, and more severe cases requiring in-
patient care. Based on the inference that immunity to severe
malaria is acquired after one or two infections [13], we assume
that recovery from infection eventually confers protection against
clinical manifestations of disease, but not against infection per se.
Hence, upon reinfection, a recovered individual (R) develops a
non-clinical form of malaria, which we will refer to as
asymptomatic infection (I2). While in the R compartment,
individuals may lose their immunity, return to S and acquire
another clinical infection (I1). Each variable represents a
proportion of the total population. At the population level,
patterns of occurrence of the two types of infection, I1 and I2, are
intertwined and our aim is to identify mechanisms consistent
with reported prevalence of hospitalised clinical malaria. We
specify rates of recovery from infection as t1 and t2, respectively,
and assume that protection wanes at a rate, a, unless boosted
by repeated exposures. The force of infection, l(a), that varies
between populations according to the value of l0, and includes
age dependence in agreement with previous studies [9], is defined
as:
l(a)~l0 1{ce
{ka
 
: ð2Þ
This function was derived from results of an entomological
study, that correlates mosquito feeds with human body mass. The
function is strictly increasing with age, with a minimum l0(12c) (at
age zero) and upper limit l0. Parameter k determines how steeply
the force of infection increases with age, and c controls the
amplitude of the increase. A summary measure of transmission is
obtained by integrating the force of infection over age as
L~
ð
l(a)P(a)da, ð3Þ
where P(a) = m e2ma, is the total population distributed over age
and m is the birth and death rate. Adopting standard assumptions,
L is proportional to the frequency of infectious individuals, the
proportionality constant being the transmission coefficient, b=L/
(I1+wI2), where w represents the relative infectivity of asymptom-
atic to clinical malaria infections.
The boundary conditions for system (1) at age a = 0 are S(t,0) = m
and R(t,0) = I1(t,0) = I2(t,0) = 0.
The data
The datasets, from eight endemic sites, consist of retrospectively
assembled data on paediatric admissions presenting from pre-
defined catchment populations with clearly defined addresses to
selected hospitals within 20km of their home, and where diagnosis
was supported by detailed clinical examination and parasitology
(see Appendix S1 for more details). Each dataset corresponds to a
different region so that the ensemble represents a general
perspective on the diversity of clinical malaria profiles, covering
the spectrum of classical hypo to holoendemic transmission, typical
of much of sub-Saharan Africa.
Parameter estimation
Parameters are characterised into global (biological parameters
intrinsic to the human host and, therefore, region-independent)
and local (environmental parameters extrinsic to the human host
and, therefore, region-specific). More specifically, we consider that
rates of recovery and waning immunity are global and the force of
infection is a local parameter [16]. As the full spectrum of clinical
malaria infections is not captured solely by hospital admissions
data, we introduce a rate of hospitalisation represented by an extra
parameter, g, which is initially assumed equal to one and later on
lowered for a sensitivity assessment. Model parameters are then
estimated by fitting the prevalence of clinical malaria, gI1, to age-
stratified hospital admission rates, using a least squares minimisa-
tion method within Berkeley Madonna v8.3.6. This is performed
by running the age-structured model and fitting the output to all
equally weighted datasets simultaneously (more details on the
fitting method can be found in Appendix S1). As for the
demographics, we assume a life expectancy of 50 years [17]. We
have confirmed that increased mortality due to clinical malaria is
negligible to our results and is, therefore, omitted.
Equilibrium analysis
Equilibrium solutions are calculated by analytically solving the
model without age structure using the global parameter values
estimated previously. The transmission coefficients, b, are
calculated by dividing the forces of infection integrated over age
obtained from equation (3) by the sum, I1+wI2, in equilibrium
conditions. We will represent the obtained equilibrium solutions as
a function of transmission intensity, which is often represented in
the form of the basic reproduction number.
The basic reproduction number
The basic reproduction number, R0, is the average number of
secondary infections generated by the introduction of a single
infectious person into an otherwise naı¨ve population. This
theoretical number is calculated by multiplying the transmission
coefficient, b, by the average duration of a primary infection, 1/
(t1+m), to obtain R0 =b/(t1+m). We stress that although R0 can be
indirectly calculated by manipulating parameters that can be
estimated from an endemic equilibrium, this number is only
meaningful when malaria is newly emerging in an immunologi-
cally naı¨ve population. When transmission is endemic, a
proportion p of infections occurs in clinically immune individuals.
These infections are likely to show no clinical symptoms, remain
untreated and transmit for a possibly different period, 1/(t2+m). In
this case, the average number of infections generated by an
infectious individual is R0 = b((12p)/(t1+m)+p/(t2+m)).
Results
Assuming, initially, the maximal hospitalisation rate, g= 1, the
estimates obtained for the global parameters and the correspond-
Figure 1. Model diagram representing the dynamics of malaria
transmission. The compartments represent the following epidemio-
logical classes: (S) completely susceptible individuals, either newborns,
or those who have lost clinical immunity; (I1) clinical malaria cases
resulting from infection of completely susceptible individuals; (R)
individuals that have recovered from any infection and are clinically
immune; (I2) asymptomatic malaria cases resulting from infection of
clinically immune individuals.
doi:10.1371/journal.pone.0001767.g001
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ing 95% confidence intervals are:
t^1~14:12 (13:90{14:36) years
1
t^2~2:23 (2:00{2:46) years
1
a^~1:07 (0:84{1:30) years1
k^~0:14 ({0:09{0:37)
c^~0:99 (0:77{1:23)
ð4Þ
From (4) we can see that, on average, individuals with clinical
malaria are infectious for a shorter time period (about 25 days)
than those with an asymptomatic infection (circa 165 days). The
duration of clinical immunity lasts for around 1 year and the age-
dependent force of infection rises from 1% to 76% of its upper
limit between ages 0 and 10 years. Under the initial assumption
that clinical cases are as infectious as mild infections, w= 1, we
estimate region-specific forces of infection as listed in Table 1,
alongside the corresponding values for the basic reproduction
number.
Figure 2 ranks the prevalence of clinical malaria and parasite
prevalence by the associated transmissibility indices estimated
under a baseline scenario (g= 1, w= 1), whose robustness is
challenged in Figures 3 and 4. Figure 2A represents the levels of
malaria morbidity in children with less than 10 years of age,
calculated as the prevalence of hospital admissions (from the data)
and the value of I1 (from the model) ranked by the estimated forces
of infection. We infer that prevalence of clinical malaria peaks at
low to intermediate transmission to gradually decline as transmis-
sion increases. This phenomenon has been termed as endemic
stability [18]. Figure 2B shows the equilibrium prevalence of
clinical malaria in terms of the basic reproduction number. The
peak of clinical malaria is again visible at low transmission,
although this effect would be less pronounced for lower rates of
waning immunity. More striking, however, is the result that the
model supports two stable equilibria for a range of R0,1.
Figure 2C represents the parasite prevalence in terms of the force
of infection, confirming qualitative agreement with previous
studies [14].
The existence of two stable equilibria for the same parameter
values is named bistability. This is generated by a positive feedback
mechanism that enhances transmission when endemicities are
established [19,20], which occurs here when recovery from a
clinical infection is faster than from asymptomatic infections
(t1.t2). This framework provides an identification of regimes
where malaria control is sustainable. Endemic and disease-free
states are separated by an unstable equilibrium that represents the
critical prevalence below which the system converges to the
Table 1. Estimated local parameters.
Region l0 (95% c.i.) L b R0
Bakau 0.14 (20.09–0.37) 0.12 NA NA
Foni Kansala 4.86 (4.63–5.09) 4.26 6.99 0.49
Sukuta 6.70 (6.47–6.93) 5.87 8.48 0.60
Mponda 14.96 (14.73–15.19) 13.10 15.52 1.10
Kilifi 19.87 (19.64–20.10) 17.40 19.77 1.40
Chonyi 47.21 (46.98–47.44) 41.35 43.66 3.08
Ifakara 50.16 (49.93–50.40) 43.94 46.25 3.27
Siaya 71.02 (70.79–71.25) 62.21 64.53 4.56
NA–The force of infection estimated for Bakau implies that this regions has
unstable malaria transmission (as can be seen in Figure 2C), which renders
inapplicable the method for calculation of b and consequently R0.
doi:10.1371/journal.pone.0001767.t001
Figure 2. Endemic stability and bistability. (A) Prevalence of
severe clinical malaria in children less than 10 years of age (grey) and
model output (black). The error bars represent a 95% confidence
interval. The eight regions are ranked by the estimated forces of
infection. (B) Equilibrium proportion of clinical malaria over all ages in
terms of R0. The full lines represent the stable solutions of the system of
differential equations, whereas the dashed lines stand for unstable
equilibria. Endemic equilibria are marked for two representative
regions: Foni Kansala and Kilifi. Alternative disease-free equilibria for
Foni Kansala is marked F. (C) Relationship between the force of infection
(or entomological inoculation rate, EIR) and the parasite prevalence. The
full line represents the stable solution of the system whereas the
dashed line stands for an unstable equilibrium.
doi:10.1371/journal.pone.0001767.g002
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disease-free state. The datasets considered in this study include
regions that are representative of the various scenarios produced
by the model. We consider three regions for illustration purposes.
In hyperendemic regions (e.g Kilifi) the endemic equilibrium is the
only stable solution, while in hypoendemic regions (e.g. Bakau),
the system shows no stable endemic equilibrium consistently with a
scenario of unstable transmission. In regions of mesoendemic
transmission (e.g Foni Kansala), however, fixed parameter values
can stably maintain a malaria-free state, or support transmission
resulting in high levels of clinical disease. The outcome is
determined by the initial conditions and can be manipulated by
specially designed and carefully monitored interventions.
In Figure 3 we analyse the sensitivity of these findings to
changes in the hospitalisation rate, g. Reducing the hospitalisation
rate systematically contracts the bistability region, which persists
until g reaches the proximity of 0.1. While lacking a rigorous
estimate for this parameter, we cannot exclude the possibility that
g is so low as to compromise the bistable behaviour. The
robustness of the bistable regime is, nevertheless, reassured when
we explore the relative infectivity of asymptomatic to clinical
infection, w. Figure 4 shows (in grey) the persistence of bistability
throughout the (w,g) parameter space. For concreteness, the
parameter combinations where bistability is predicted for Foni
Kansala are also marked (in dark grey). Recent empirical studies
[21] suggest that asymptomatic infections are more infective than
clinical infections, indicating that w.1. Coincidentally, the
analysis demonstrates that increasing w enhances the bistability
phenomenon favouring the realism of our findings.
Discussion
Confronting a mathematical model with observed age profiles of
clinical malaria, we obtain estimates for the parameters underlying
the dynamics of transmission. In particular, rates of recovery from
infection are obtained indicating that, on average, individuals with
clinical malaria are infectious for a shorter time period than those
with an asymptomatic infection. We attribute this mainly to
behavioural factors. A clinical infection is likely to lead to
Figure 3. Sensitivity to hospitalisation rate, parameter g. (A) Equilibrium curves for different values of g (1, 0.6, 0.4, 0.2, from lower to higher
peak). (B) Estimated basic reproduction numbers for different values of g. The black full line on the left shows the lower value of R0 for which an
endemic equilibrium solution exists. The red and green dotted lines represent the values of R0, derived from the estimated forces of infection, for Foni
Kansala and Kilifi, respectively. Circles highlight the values of gcorresponding to the curves in (A).
doi:10.1371/journal.pone.0001767.g003
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administration of anti-malarials and faster recovery. This trend is
consistent with estimates obtained from epidemiological observa-
tions of populations under treatment, where the average duration
of infection was brought down from 270 to 14 days by
administration of drugs [22].
Consistently with previous observations [6,23] we describe a
peak of prevalence of clinical malaria at low to intermediate
transmission (Figure 2A). This is due to the phenomenon of
endemic stability, which in our model is attributed to the dynamics
of infection and immunity as follows. Under high force of
infection, clinical immunity is maintained through repeated
infections, and clinical cases become relatively rare. If the force
of infection is reduced, clinical immunity wanes and the potential
for occurrence of clinical cases, increases. Clinically immune
individuals can either be reinfected and boost their immunity at
rate L, or lose immunity at rate a. While L prevents the return to
the susceptibility pool for clinical malaria, a has the opposite effect
of generating more susceptibles. Since a is a global parameter, a
peak in clinical disease is expected to occur as L varies across
regions. This general model, applicable to malaria and other
diseases (e.g. pertussis [24]), implies that interventions that reduce
transmission should be combined with effective management of
clinical cases to prevent any undesired increase in disease burden.
These profound implications to control planning have motivated
more detailed and highly controlled epidemiological studies [25].
Our results have no implications to this ongoing debate as the
model used here does not take explicit account of specific
syndromes of severe malaria nor mortality.
More relevant to malaria control, is the finding of bistable
behaviour in regions of mesoendemic transmission, such as Foni
Kansala and Sukuta. Bistability is generated by the establishment
of longer infections in clinically immune individuals, in compar-
ison to infections in those that are immunologically naı¨ve. This
asymmetry, which enhances transmission when endemicities are
established, leads to the identification of conditions for sustainable
malaria control. Interventions in the field have accumulated
unsuccessful eradication attempts in regions of hyper to holoen-
demic transmission, such as the Garki district in Nigeria [26], in
contrast with successful eradication initiatives taken place in areas
of hypo or mesoendemic transmission, such as the highlands of
Papua New Guinea (PNG), most of the South African territory,
the midlevel area of Swaziland, and Sri Lanka [27–29]. In recent
years, however, some of these areas (Sri Lanka and the highlands
of PNG) have experienced malaria resurgence. This epidemiolog-
ical change, which can be attributed to both the relaxation of
control measures and population migration between these
locations and areas where malaria is endemic [29,30], is consistent
with the regime R0,1 in Figure 2B, where either malaria free
(horizontal branch) or endemic (higher branch) states are stable
once established. Unstable malaria transmission is an epidemio-
logical scenario that, while also falling into the R0,1 regime,
represents regions (such as Bakau) where patterns of clinical
malaria incidence are consistent with perturbations of the malaria-
free state rather than a stable endemic state.
A practical tool for control planning comes from the observation
that the two epidemiological states are separated by an unstable
state (dashed branch) indicating a threshold for either eradication
or resurgence. This threshold, expressed in terms of parasite
prevalence, or other measures convenient to intervention design, is
reduced if the typical duration of infection increases. Stability of
the malaria-free state relies, therefore, on a system of early
detection and response, whose purpose is to shorten the infectious
period of parasite-positive individuals through antimalarial
treatment. Shifts from disease-free to endemic states are usually
triggered by a sufficiently intense migration from endemic regions,
and can be prevented by early detection and treatment of malaria
infections irrespective of symptoms [29]. Therefore, to achieve
malaria eradication in areas of hypo and mesoendemic transmis-
sion, an integrated effort between those regions and their
contiguous hyper and holoendemic regions is imperative.
Conditions for eradication and resurgence are simulated in
Appendix S1.
The model adopted here is consistent with previous models in
malaria epidemiology [11,12] and embodies plausible hypotheses
about the natural history of malaria infection. Age dependence is
especially elaborated so the model output can be adjusted to age-
stratified datasets. As the model is intended to reproduce age
profiles of annual hospital admissions, those transitions that do not
directly affect the clinical malaria compartment are simplified.
The most significant reductions refer to the explicit details of how
immunity is maintained and the mosquito section of the
transmission cycle. Although models often differ in the exact
details of super- and re-infection, they are consensual in that
immunity is boosted by repeated exposure. The originality of our
procedure is the estimation of independent infection and recovery
parameters for naı¨ve and clinically immune individuals, indicating
that the best fits to age profiles of clinical malaria are obtained
when asymptomatic infections are greater contributors to
transmission due to their larger infectious period. Other authors
did not capture this behaviour because they imposed that
asymptomatic infections were not infectious [11,12]. Our model
challenges this assumption, in agreement with the measured
gametocyte densities [21] and the growing perception that mass
administration of antimarial drugs should be an important
component of malaria eradication strategies [31–33].
Mosquito population and infection dynamics is another classical
topic in malaria research that has recently recovered attention
from modellers [34–36]. Although we do not expect explicit details
on this part of the cycle to impact qualitatively on the bistability
mechanism, this should be carefully considered on any model
Figure 4. Parameter region for the existence of bistability. The
grey area represents the region of parameters in which bistability is
obtained. The darker grey area defines the conditions for bistability in
Foni Kansala.
doi:10.1371/journal.pone.0001767.g004
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extension intended to guide interventions in specific settings where
malaria is seasonal.
Finally, the results presented here have important implications
for the interpretation of measured indices of transmission. The
basic reproduction number for malaria has recently been
reformulated to consider heterogeneity in biting rates, resulting
in an increase of R0 estimates in regions of holoendemic
transmission by an order of magnitude [14]. Here we are
concerned with the other end of the range and show the opposite
effect: due to a backward bifurcation, the values of R0 estimated
directly in mesoendemic scenarios may appear higher than the
number of secondary infections that would be generated by the
introduction of a single infectious person into an otherwise naı¨ve
population. For concreteness, we calculate, from the endemic
equilibrium solutions, the proportion, p, of infections which occurs
in clinically immune individuals, and obtain values between 0.95
and 0.99 depending on the region considered. As for the recovery
rate, t2, this has been estimated as approximately 6.3 times lower
than t1. Replacing these values in the formula above given in
Methods, we would obtain an ‘‘apparent’’ R0<6.3b/(t1+m), which
is about 6 times higher than the ‘‘true’’ basic reproduction
number. As a consequence, malaria eradication in those regions
appears more viable than previously thought.
Supporting Information
Appendix S1
Found at: doi:10.1371/journal.pone.0001767.s001 (0.39 MB
PDF)
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